Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1981;3:340-346

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallin, B. G.
Right arrow Articles by Frisk-Holmberg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallin, B. G.
Right arrow Articles by Frisk-Holmberg, M.

Hypertension, Vol 3, 340-346, Copyright © 1981 by American Heart Association


ARTICLES

The antihypertensive mechanism of clonidine in man. Evidence against a generalized reduction of sympathetic activity

BG Wallin and M Frisk-Holmberg

Recording of multi-unit sympathetic activity were made from muscle branches of the peroneal nerve during i.v. bolus injection of 100 to 275 micrograms clonidine in seven hypertensive patients. Blood pressure was reduced in all patients, but sympathetic activity and heart rate could either increase or decrease. When plasma levels of clonidine were low, sympathetic activity tended to increase, and when plasma levels were high, activity tended to decrease. Irrespective of whether mean level of sympathetic activity increased or decreased with the fall in blood pressure level, transient fluctuations of blood pressure continued to cause dynamic baroreflex modulation of the sympathetic outflow. It is suggested that the drug influences sympathetic outflow by a combination of central and peripheral effects.


This article has been cited by other articles:


Home page
HypertensionHome page
Q. Fu, R. Zhang, S. Witkowski, A. Arbab-Zadeh, A. Prasad, K. Okazaki, and B. D. Levine
Persistent Sympathetic Activation During Chronic Antihypertensive Therapy: A Potential Mechanism for Long Term Morbidity?
Hypertension, April 1, 2005; 45(4): 513 - 521.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, C. Turri, G. Bolla, and G. Mancia
Short-Versus Long-Term Effects of Different Dihydropyridines on Sympathetic and Baroreflex Function in Hypertension
Hypertension, March 1, 2003; 41(3): 558 - 562.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. R. Azevedo, G. E. Newton, and J. D. Parker
Cardiac and systemic sympathetic activity in response to clonidine in human heart failure
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. C. Lang, C. M. Stein, H. B. He, F. J. Belas, I. A. Blair, M. Wood, and A. J. J. Wood
Blunted Blood Pressure Response to Central Sympathoinhibition in Normotensive Blacks : Increased Importance of Nonsympathetic Factors in Blood Pressure Maintenance in Blacks
Hypertension, August 1, 1997; 30(2): 157 - 162.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Noll, R. R. Wenzel, S. de Marchi, S. Shaw, and T. F. Luscher
Differential Effects of Captopril and Nitrates on Muscle Sympathetic Nerve Activity in Volunteers
Circulation, May 6, 1997; 95(9): 2286 - 2292.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
D. S. GOLDSTEIN, P. D. LEVINSON, R. ZIMLICHMAN, A. PITTERMAN, R. STULL, and H. R. KEISER
Clonidine Suppression Testing in Essential Hypertension
Ann Intern Med, January 1, 1985; 102(1): 42 - 48.
[Abstract] [PDF]